Veracyte | Vermögenswerte

Aktienkurs
36.59
Täglich Wechseln
-2.16 -5.57%
Monatlich
-4.91%
Jährlich
5.26%
Q1 Prognose
35.46




Vermögenswerte Veränderung Datum
Agenus USD 233.89M 48.67M 2025-09
Agilent USD 12.81B 86M 2025-12
Anika Therapeutics USD 189.44M 1.76M 2025-09
Arrowhead Research USD 1.6B 218.89M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Exact Sciences USD 5.86B 39.38M 2025-12
Heron Therapeutics USD 248.95M 16.86M 2025-09
Illumina USD 6.64B 467M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Laboratory Of America USD 18.39B 131.1M 2025-12
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
Myriad Genetics USD 728.1M 50.8M 2025-09
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Siemens EUR 170.13B 3.93B 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Veracyte USD 1.41B 38.23M 2025-12
Waters USD 5.08B 221.41M 2025-12


Veracyte Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.